First-in-Human Trial: PARP1/2 imaging with 18F-PARPi in head and neck cancer. https://t.co/Rr2kdWC7yf https://t.co/60X1ds8yNC
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer https://t.co/N86ONrLw8C
RT @LewisLabMSKCC: Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer https://t.co/ORAoJgqpsF
RT @LewisLabMSKCC: Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer https://t.co/ORAoJgqpsF
RT @LewisLabMSKCC: Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer https://t.co/ORAoJgqpsF
RT @LewisLabMSKCC: Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer https://t.co/ORAoJgqpsF
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer https://t.co/ORAoJgqpsF
Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer https://t.co/qBCVsEUwcK
RT @NatRevClinOncol: in first-in-human trial to determine safety and feasibility of PET imaging with 18F-PARPi in 11 pts with head and neck…
RT @ImagingT: Successful clinical trial from our lab (Reiner)- cancer imaging (PARP 1/2) with 18F-PARPi in patients with head and neck canc…
RT @ImagingT: Successful clinical trial from our lab (Reiner)- cancer imaging (PARP 1/2) with 18F-PARPi in patients with head and neck canc…
RT @NatRevClinOncol: in first-in-human trial to determine safety and feasibility of PET imaging with 18F-PARPi in 11 pts with head and neck…
RT @NatRevClinOncol: in first-in-human trial to determine safety and feasibility of PET imaging with 18F-PARPi in 11 pts with head and neck…
@BrennanSurgeon
in first-in-human trial to determine safety and feasibility of PET imaging with 18F-PARPi in 11 pts with head and neck cancer, 18F-PARPi enabled detection of primary and metastatic lesions, and retention was longer in tumours than in non-transf tissues htt
18F-PARPi for head and neck cancer imaging. Happy to be part of it. @CCR_AACR
RT @ImagingT: Successful clinical trial from our lab (Reiner)- cancer imaging (PARP 1/2) with 18F-PARPi in patients with head and neck canc…
RT @ImagingT: Successful clinical trial from our lab (Reiner)- cancer imaging (PARP 1/2) with 18F-PARPi in patients with head and neck canc…
RT @ImagingT: Successful clinical trial from our lab (Reiner)- cancer imaging (PARP 1/2) with 18F-PARPi in patients with head and neck canc…
Successful clinical trial from our lab (Reiner)- cancer imaging (PARP 1/2) with 18F-PARPi in patients with head and neck cancer. Check out our work @CCR_AACR @sloan_kettering @ImagingT @Chris_from_NY @paulademetrio09 @LewisLabMSKCC #research #science https
Safety and feasibility of PARP1/2 imaging with 18F-PARPi in patients with head and neck cancer https://t.co/UfN0YBtGvo